Focused on determining the mechanisms of human disease and advancing new technologies to translate these insights into therapeutics through in-house biotech.
US stocks finished solidly higher Tuesday, shaking off early weakness on continued bullish sentiment as a mixed inflation report contributed to a drop in oil prices.